MIR4752

Across TCGA pan-cancer cohorts, MIR4752 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR4752 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR4752 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4752 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BRCA, COAD, and SKCM are the cancer types where MIR4752 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	II,III,IV	0.614	0.891	.003	36	view →
COAD	OS	Tertile	All	0.168	0.799	.004	36	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	27	view →
KIRC	OS	Tertile	II,III,IV	0.166	0.532	.033	18	view →
LUAD	OS	Tertile	III,IV	0.068	0.680	<.001	18	view →
ESCA	DFS	Tertile	III,IV	1.000	0.278	.034	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR4752–BRCA (DFS)

Open the BRCA breakdown →